Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families

European Journal of Paediatric Neurology

Volumn 2, Issue 5, 1998, Pages 255-261

  Melis, M A ^a   Cau, M ^a   Muntoni, F ^b   Mateddu, A ^a   Galanello, R ^a   Boccone, L ^a   Deidda, F ^a   Loi, D ^a   Cao, A ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Becker muscular dystrophy; Deletion; Dystrophinopathy

Indexed keywords

CREATINE KINASE; DYSTROPHIN;

ARTICLE; CASE REPORT; CHILD; DISEASE SEVERITY; EXON; GENE DELETION; HUMAN; MOLECULAR GENETICS; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; PRIORITY JOURNAL;

EID: 0031798117     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3798(98)80039-1     Document Type: Article

References (34)

1. Koenig M, Hoffman EP, Bertelson CJ et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987; 50: 509-517.
2. Koenig M, Beggs AH, Moyer M et al. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am J Hum Genet 1989; 45: 498-506.
3. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nature Genet 1993; 3: 283-291.
4. Nicholson LVB, Johnson MA, Bushby KMD et al. Integrated study of 100 patients with Wp 21-linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2: Correlation within individual patients. J Med Genet 1993; 30: 737-744.
5. Forrest SM, Cross GS, Flint T et al. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics 1988; 2: 109-114.
6. Gillard EF, Chamberlain JS, Murphy EG et al. Molecular and phenotypic analysis of patient with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 1989; 45: 507-520
7. den Dunnen JT, Grootscholten PM, Bakker E et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveal 115 deletions and 13 duplications. Am J Hum Genet 1989; 45: 835-847.
8. Monaco AP, Bertelson CJ, Liechti-Gallati S et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2: 90-95.
9. Chelly J, Gilgenkrantz H, Lambert M et al. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell 1990; 63: 1239-1248.
10. Beggs AH, Hoffman EP, Snyder JR et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies. Am J Hum Genet 1991; 49: 54-68.
11. Malhotra SB, Hart KA, Klamut HJ et al. Frameshift deletions in patients with Duchenne and Becker muscular dystrophy. Science 1988; 242: 755-759.
12. Winnard AV, Klein CJ, Coovert DD et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Molec Genet 1993; 2: 737-744.
13. Fanin M, Freda MP, Vitiello L et al. Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size? Muscle Nerve 1996; 19: 1154-1160.
14. Takeshima Y, Nishio H, Narita N et al. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype. Neurology 1994; 44: 1648-1651.
15. Muntoni F, Gobbi P, Sewry C et al. Deletions in the 5′ region of dystrophin and resulting phenotypes. J Med Genet 1994; 31: 843-847.
16. Ishigaki C, Patria SY, Nishio H et al. A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene. Neurology 1996; 46: 1347-1350.
17. Muntoni F, Cau M, Ganau A et al. Brief report: deletion of the dystrophin muscle promoter region associated with X-linked dilated cardiomiopathy. New Engl J Med 1993; 329: 921-925.
18. Doriguzzi C, Palmucci L, Mongini T et al. Exercise intolerance and recurrent mycoglobinuria as the only expression of Xp21 Becker type muscular dystrophy. J Neurol 1993; 240: 269-271.
19. Nordenskjold M, Nicholson L, Edstrom L et al. A normal male with an inherited deletion of one exon within the DMD gene. Hum Genet 1990; 84: 207-209.
20. Collins AL, Leyland KG, Kennedy CR et al. An inherited dystrophin deletion without muscle weakness. [letter] J Med Genet 1994; 31: 505.
21. Palmucci L, Doriguzzi C, Mongini T et al. Unusual expression and very mild course of Xp21 muscular dystrophy (Becker type) in a 60-year-old man with 26 percent deletion of the dystrophin gene. Neurology 1994; 44: 541-543.
22. Heald A, Anderson LVB, Bushby KMD, Show PJ. Becker muscular dystrophy with onset after 60 years. Neurology 1994; 44: 2388-2390.
23. Morrone A, Zammarchi E, Scacheri PC. Asymptomatic dystrophinopathy. Am J Med Genet 1997; 69: 261-267.
24. Chamberlain JS, Gibbs RA, Ranier JE et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 1988; 23: 11141-11156.
25. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990; 86: 45-48.
26. Covone AE, Lerone M, Romeo G. Genotype-phenotype correlation and germline mosaicism in DMD/ BMD patients with deletions of the dystrophin gene. Hum Genet 1991; 87: 353-360.
27. Schwartz LS, Tarleton J, Popovich B et al. Fluorescent multiplex linkage analysis and carrier detection for Duchenne-Becker muscular dystrophy. Am J Hum Genet 1992; 51: 721-729.
28. Roberts RG, Barby TFM, Manners E et al. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991; 49: 298-310.
29. Dubowitz V. Muscle Biopsy: A Practical Approach (2nd edn). Eastbourne: Baillière-Tindall, 1985.
30. Beggs AH, Hoffman EP, Snyder JR et al. Exploring the molecular basis for variability among patients with Becker Muscular Dystrophy: dystrophin gene and protein studies. Am J Hum Genet 1991; 49: 54-67.
31. Matsumura K, Nonaka. I, Tomè FMS et al. Mild deficiency of dystrophin associated proteins in Becker muscular dystrophy patients having inframe deletions in the rod-domain of dystrophin. Am J Hum Genet 1993; 53: 409-416.
32. Muntoni F, Di Lenarda A, Porcu M et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart 1997; 78: 608-612.
33. Vainzof M, Passos-Bueno MR, Takata RI et al. Intrafamilial variability in dystrophin abundance correlated with difference in the severity of the phenotype. J Neural Sci 1993; 119: 38-42.
34. Wilton SD, Johnsen RD, Pedrettoi JR, Laing NG. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. Am J Med Genet 1993; 46: 563-569.